A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
Clinical trial NCT02495922 · COMPLETED
Trial details
- NCT number
- NCT02495922
- Sponsor
- University of Heidelberg Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2021-06-24
- Enrollment
- 564
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.